Evaluation of Mapmydiabetes, the NICE-endorsed diabetes self-management education platform

对 NICE 认可的糖尿病自我管理教育平台 Mapmydiabetes 的评估

• 批准号: 133678
• 金额: $ 3.17万
• 依托单位: MAPMYHEALTH LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2018
• 资助国家: 英国
• 起止时间: 2018 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=133678
• 关键词: Evaluation; Mapmydiabetes; NICE; endorsed; diabetes

"Diabetes is a major public health problem with almost 3.7 million people diagnosed in the UK and an estimated 1 million more who are undiagnosed. Obesity is the most significant risk factor for developing type 2 diabetes, which accounts for 90% of all cases. Good diabetes management has been shown to reduce the risk of complications (blindness, heart disease, stroke, kidney disease and amputations). There is also a substantial financial cost to diabetes care, estimated at £14 billion per year in the UK.All people with diabetes should be offered diabetes self-management education and support around the time they are diagnosed, with annual reinforcement and review. Unfortunately, referral and access to this education and support is highly variable across the UK and annual reinforcement rarely happens. There are many reasons for this, including lack of capacity in the system, but also because many people can't, or don't want to attend classroom-based group sessions, which has until recently been the only way to access diabetes self-management education.Mapmydiabetes can make a significant difference to people living with diabetes and to the cost and efficiency of delivering this care by providing diabetes self-management education through digital channels. Mapmydiabetes is a web-based support platform that provides unlimited and ongoing access to education, support and self-management tools for people with diabetes, and also connects them to their healthcare provider to support shared clinical decision-making.The broad adoption of Mapmydiabetes by the NHS is being hindered by lack of a clinical and cost effectiveness evidence base, which prevents the NHS from committing to and commissioning this service. This project aims to develop a data collection and evaluation plan to generate a robust evidence base for Mapmydiabetes that will be acceptable to key stakeholder groups, including NICE, NHS England and Clinical Commissioning Groups. This will enable Mapmydiabetes to be adopted at pace and scale within the NHS to bring real benefits to people living with diabetes as well as reduce the costs of service proviison to the NHS."

“糖尿病是一个主要的公共卫生问题，在英国有近370万人被确诊，估计还有100万人未被确诊。肥胖是发展2型糖尿病的最重要的危险因素，占所有病例的90%。良好的糖尿病管理已被证明可以降低并发症（失明、心脏病、中风、肾病和截肢）的风险。糖尿病护理也有相当大的财务成本，估计每年在英国为140亿英镑。所有糖尿病患者都应该在被诊断出糖尿病的时候提供糖尿病自我管理教育和支持，并每年进行强化和审查。不幸的是，转介和获得这种教育和支持是高度可变的整个英国和年度加固很少发生。造成这种情况的原因有很多，包括系统中缺乏能力，但也因为许多人不能或不想参加以课堂为基础的小组会议，直到最近，这一直是获得糖尿病自我管理教育的唯一途径。Mapmydiabetes可以通过提供糖尿病自我管理教育，为糖尿病患者以及提供这种护理的成本和效率带来显着变化。通过数字渠道进行管理教育。Mapmydiabetes是一个基于网络的支持平台，为糖尿病患者提供无限制和持续的教育，支持和自我管理工具，并将他们连接到他们的医疗保健提供者，以支持共享的临床决策。由于缺乏临床和成本效益的证据基础，NHS对Mapmydiabetes的广泛采用受到阻碍，这阻止了NHS承诺和委托这项服务。该项目旨在制定一个数据收集和评估计划，为Mapmydiabetes生成一个强大的证据基础，该证据基础将为关键利益相关者群体所接受，包括NICE，NHS英格兰和临床调试组。这将使Mapmydiabetes能够在NHS内以一定的速度和规模被采用，为糖尿病患者带来真实的好处，并降低NHS的服务提供成本。"